342 related articles for article (PubMed ID: 34299347)
1. Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP).
Markowicz-Piasecka M; Huttunen J; Montaser A; Adla SK; Auriola S; Lehtonen M; Huttunen KM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299347
[TBL] [Abstract][Full Text] [Related]
2. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.
Rhee MS; Schneider E
Biochem Pharmacol; 2005 Jan; 69(1):123-32. PubMed ID: 15588721
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
4. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing.
Adachi M; Sampath J; Lan LB; Sun D; Hargrove P; Flatley R; Tatum A; Edwards MZ; Wezeman M; Matherly L; Drake R; Schuetz J
J Biol Chem; 2002 Oct; 277(41):38998-9004. PubMed ID: 12105214
[TBL] [Abstract][Full Text] [Related]
5. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
[TBL] [Abstract][Full Text] [Related]
6. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
7. Cooperative therapeutic effects of herpes simplex virus thymidine kinase gene/ganciclovir system and chemotherapeutic agents on prostate cancer in vitro.
Xing Y; Xiao Y; Lu G; Zeng F; Zhao J; Xiong P; Feng W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):610-3. PubMed ID: 17219983
[TBL] [Abstract][Full Text] [Related]
8. Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner.
Huttunen J; Tampio J; Järvinen J; Montaser AB; Markowicz-Piasecka M; Huttunen KM
Chem Biol Interact; 2024 Jan; 388():110833. PubMed ID: 38101600
[TBL] [Abstract][Full Text] [Related]
9. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.
Volk EL; Farley KM; Wu Y; Li F; Robey RW; Schneider E
Cancer Res; 2002 Sep; 62(17):5035-40. PubMed ID: 12208758
[TBL] [Abstract][Full Text] [Related]
11. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
12. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk EL; Schneider E
Cancer Res; 2003 Sep; 63(17):5538-43. PubMed ID: 14500392
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
14. The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells.
Zeng ZJ; Xiang SG; Xue WW; Li HD; Ma N; Ren ZJ; Xu ZJ; Jiao CH; Wang CY; Hu WX
Biomed Pharmacother; 2014 Sep; 68(7):887-92. PubMed ID: 25217394
[TBL] [Abstract][Full Text] [Related]
15. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
16. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
[TBL] [Abstract][Full Text] [Related]
17. Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate.
Finzi L; Kraemer A; Capron C; Noullet S; Goere D; Penna C; Nordlinger B; Legagneux J; Emile JF; Malafosse R
J Exp Clin Cancer Res; 2011 Oct; 30(1):92. PubMed ID: 21970612
[TBL] [Abstract][Full Text] [Related]
18. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
Zhang YH; Li G; Yu J; Xu MS; Liu ZX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
[TBL] [Abstract][Full Text] [Related]
20. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro.
Freund CT; Tong XW; Rowley D; Engehausen D; Frolov A; Kieback DG; Lerner SP
Urol Oncol; 2003; 21(3):197-205. PubMed ID: 12810206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
